Riskpilot← Back to searchSign inGet full accessSPERMOSENS AB
ABActiveOrg 5591790380LundResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20181-4 employees
Revenue 2024
—
EBITDA margin
—
Equity ratio
—
Financial strength
Net profit 2024
—
| Revenue | — | — |
| EBITDA | SEK 0 | — |
| Net profit | — | — |
| Total assets | — | — |
| Equity | — | — |
| Employees | — | — |
Legal name
SPERMOSENS AB
Org number
5591790380
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
8 november 2018
Share capital
SEK 4 119 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Firman tecknas av en av ledamöterna i förening med Duvold, Tore Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva forskning, utveckling, tillverkning och försäljning av produkter för manlig fertilitetsdiagnostik och behandling samt idka därmed förenlig verksamhet.
Address
Lund
Email
info@spermosens.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 7 | 38 | 0 | 0 | — |
| Staff expenses | — | — | — | — | — | — |
| EBITDA | 26 | −2 042 | −6 151 | −12 454 | −10 873 | 0 |
| Depreciation & amort. | −0 | −0 | −0 | −63 | −0 | — |
| EBIT | 26 | −2 042 | −6 151 | −12 517 | −10 873 | 0 |
| Net financials | — | −3 | −272 | −129 | −1 329 | — |
| Profit before tax | 26 | −2 045 | −6 423 | −12 646 | −12 202 | 0 |
| Tax | −6 | −0 | −0 | −0 | −0 | — |
| Net profit | 20 | −2 045 | −6 423 | −12 646 | −12 202 | — |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 3 063 | 9 937 | 25 679 | 33 399 | 26 105 | — |
| Equity | 2 630 | 3 420 | 23 638 | 29 564 | 12 692 | — |
| Long-term debt | 0 | 500 | 365 | 1 235 | 230 | — |
| Short-term debt | 433 | 6 018 | 1 676 | 2 600 | 13 183 | — |
| Total debt | 433 | 6 518 | 2 041 | 3 835 | 13 413 | — |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20192024
Equity ratio
0.0%
This company
38.2%
Market median
-100% vs market
20192024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20192024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20192024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192024
Debt / equity
-1.00×
This company
0.62×
Market median
+261% vs market
20192024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-11-01 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AH Chief Auditor | Chief Auditor | 2022 | — | — |
TD Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
HU Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
BA Chief Auditor | Chief Auditor | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2024 | — | — | |
| Chairman | 2020 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SPERMOSENS AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Andreas Henrik Alexander Brodström | Chief Auditor | 0 companies |
| Tore Duvold | Chief Executive Officer | 0 companies |
| Hans-Olof Ulrik Nilsson | Chief Executive Officer | 0 companies |
| Bengt Anders Ekenberg | Chief Auditor | 0 companies |
| Sudha Srivastava | Board of Directors | 0 companies |
| Eva Ingela B Liljeqvist Soltic | Board of Directors | 0 companies |
| Mohamad Takwa | Board of Directors | 0 companies |
| Kushagr Punyani | Board of Directors | 0 companies |
| Majken Christina Lloyd | Board of Directors | 0 companies |
| Erik Gustav Björn Wendel | Chairman | 0 companies |
| Sören Melsing Frederiksen | Board of Directors | 0 companies |
| John Erik Andersson Moll | Board of Directors | 0 companies |
| Ulrik Spork | Chairman | 0 companies |
| Eva Alva Maria Nilsagård | Chairman | 0 companies |